Trials / Completed
CompletedNCT03903094
A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
A Retrospective Database Analysis of Anticholinergic Burden Among the Elderly With and Without Overactive Bladder in Australia and South Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,295,279 (actual)
- Sponsor
- Astellas Pharma Singapore Pte. Ltd. · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Outpatients with at least one dispensing record of any medication will be included in the study. An index date will be assigned to each participant and prescription records for anticholinergics will be used in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Overview of anticholinergic burden, rather than to evaluate specific drugs |
Timeline
- Start date
- 2019-03-07
- Primary completion
- 2022-05-06
- Completion
- 2022-05-06
- First posted
- 2019-04-04
- Last updated
- 2024-10-31
Locations
2 sites across 2 countries: Australia, South Korea
Source: ClinicalTrials.gov record NCT03903094. Inclusion in this directory is not an endorsement.